Screener
Axsome Therapeutics AXSM Payment Of Contingent Consideration
Payment Of Contingent Consideration at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept axsm:PaymentOfContingentConsideration.
The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 5:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204274
FAQ
- What is Axsome Therapeutics's payment of contingent consideration?
- Axsome Therapeutics (AXSM) reported payment of contingent consideration of -$3.26M in Q1 2026.
- How has Axsome Therapeutics's payment of contingent consideration changed year-over-year?
- Axsome Therapeutics's payment of contingent consideration decreased by 42.8% year-over-year, from -$2.29M to -$3.26M.
- What is the long-term trend for Axsome Therapeutics's payment of contingent consideration?
- Over 2 years (2023 to 2025), Axsome Therapeutics's payment of contingent consideration has grown at a 26.5% compound annual growth rate (CAGR), from -$6.21M to -$9.94M.
- What does payment of contingent consideration mean?
- This represents cash payments made to satisfy earn-out or milestone-based obligations resulting from past business acquisitions. These payments are triggered when specific performance or development goals are achieved.
Ask your AI about Axsome Therapeutics's payment of contingent consideration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude